What is the most recent earnings date for JBIO stock?
JADE BIOSCIENCES INC (JBIO) last reported earnings on 3/6/2026.
NASDAQ:JBIO • US0080642061
Past quarterly earnings results for JADE BIOSCIENCES INC (JBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.59 | -0.48 | -21.95% | 91.11% | - | - | ||
| Q3 2025 | -0.48 | -0.69 | 30.18% | 97.55% | - | - | ||
| Q2 2025 | -0.86 | -0.44 | -94.83% | 97.14% | - | - | ||
| Q1 2025 | -3.15 | -8.57 | 63.24% | 89.16% | - | - | ||
| Q4 2024 | -6.65 | -8.93 | 25.49% | 74.32% | - | - | ||
| Q3 2024 | -19.60 | -20.80 | 5.75% | 21.13% | - | - | ||
| Q2 2024 | -30.10 | -29.35 | -2.57% | -13.16% | - | - | ||
| Q1 2024 | -29.05 | -27.31 | -6.37% | -23.88% | - | - | ||
| Q4 2023 | -25.90 | -25.26 | -2.52% | -21.31% | - | - | ||
| Q3 2023 | -24.85 | -24.69 | -0.65% | -26.79% | - | - | ||
| Q2 2023 | -26.60 | -24.85 | -7.05% | -55.10% | - | - | ||
| Q1 2023 | -23.45 | -21.42 | -9.48% | -48.89% | - | - | ||
| Q4 2022 | -21.35 | -22.06 | 3.20% | -74.29% | - | - | ||
| Q3 2022 | -19.60 | -17.79 | -10.19% | -115.38% | - | - | ||
| Q2 2022 | -17.15 | -16.23 | -5.64% | 97.94% | - | - | ||
| Q1 2022 | -15.75 | -9.91 | -58.98% | - | - | - | ||
| Q4 2021 | -12.25 | -10.98 | -11.59% | - | - | - | ||
| Q3 2021 | -9.10 | -9.28 | 1.96% | - | - | - | ||
| Q2 2021 | -833.00 | -5.59 | -14,793.30% | - | - | - | ||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
JADE BIOSCIENCES INC (JBIO) last reported earnings on 3/6/2026.
JADE BIOSCIENCES INC (JBIO) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, JADE BIOSCIENCES INC (JBIO) has beaten EPS estimates in 2 out of 4 releases.